BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 8, 2023
Distillery Therapeutics

An anti-citrullinated protein mAb with therapeutic effects in RA

BioCentury | Aug 21, 2021
Targets & Mechanisms

Next-generation multiple sclerosis therapies look beyond B cells 

Early-stage approaches aim for more precise immune suppression, remyelination
BioCentury | Nov 30, 2018
Targets & Mechanisms

Adhesion targets emerge at ASH 2018

Emerging science on adhesion molecules, RNA-binding proteins and more at ASH 2018
BioCentury | Oct 11, 2018
Distillery Therapeutics

Cardiovascular

BioCentury | Jun 18, 2015
Distillery Therapeutics

Therapeutics: Enolase 1 α (ENO1)

BioCentury | Jun 18, 2015
Translation in Brief

Peptide guide to colon cancer

How a peptide targets cancer drugs to colon cancers
BioCentury | Sep 6, 2012
Distillery Therapeutics

Indication: Cancer

BioCentury | Sep 6, 2012
Targets & Mechanisms

Passenger mutations take the wheel

BioCentury | Feb 12, 2009
Distillery Therapeutics

Indication: Infectious disease

Items per page:
1 - 9 of 9